Micronoma Closes $3.5M Convertible Debt Financing Round

23 Feb, 2021

Micronoma Closes $3.5M Convertible Debt Financing Round
Photo by Ryoji Iwata on Unsplash

– Micronoma is a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology.
– The company closed a $3.5m convertible debt financing round.
– Backers included SymBiosis, LLC and The Seerave Foundation.
– The investments bring the company’s total amount of funding to $6.5m since the first seed round six months ago.

Biotechnology Health Care Health Diagnostics Life Science North America
Crunchbase icon

Content report

The following text will be sent to our editors: